Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?
Curr Urol Rep. 2007 Sep;8(5):419-24
Authors: Unwala DJ, Barboglio P, Gousse AE
Botulinum toxin A (BTX-A) has emerged as a novel treatment option for idiopathic overactive bladder (OAB) refractory to antimuscarinic agents. The clinical needs of refractory OAB patients have been recently met by sacral neuromodulation and augmentation enterocystoplasty. Important features of BTX-A should include safety, efficacy, and ease of delivery during long-term repeated usage. This article reviews the role of repeated BTX-A injections in the treatment of idiopathic OAB.
PMID: 17880843 [PubMed - indexed for MEDLINE]
]]>View the Original article